Blindsight, the experimental vision-restoring implant by Elon Musk’s brain-chip startup, Neuralink, has received the U.S. Food and Drug Administration’s (FDA) "breakthrough device" designation, according to the company.

Elon Musk's brain-chip startup Neuralink said on Tuesday its experimental implant aimed at restoring vision received the U.S. Food and Drug Administration's "breakthrough device" designation.

Industrialist Anand Mahindra on Thursday praised Elon Musk's Blindsight device from its brain-chip startup Neuralink, saying that it would be the tech mogul's "most enduring gift to humankind".

Elon Musk's brain-chip startup Neuralink announces its experimental implant can restore vision, receives US FDA 'breakthrough device' designation.

The FDA’s breakthrough tag is given to certain medical devices that provide treatment or diagnosis of life-threatening conditions

Tesla CEO Elon Musk has announced that Neuralink, his brain-chip startup company, has received approval from the US Food and Drug Administration (FDA) for an

Elon Musk's brain-chip startup Neuralink said on Tuesday its implant had received the U.S. Food and Drug Administration's "breakthrough device" designation. (Reporting by Bhanvi Satija in Bengaluru; E

The regulatory approval is just the first phase of a long project, but Neuralink owner Elon Musk is already touting his brain implant tech as a world-changing solution for people with vision loss.

Elon Musk’s Neuralink has recently achieved a significant milestone with its experimental vision-restoring implant, Blindsight. The U.S. Food and Drug Administration (FDA) has granted the device a "Breakthrough Device" designation,